As recommended in the WHO management guideline for HIV and TB co-infection, cART should be administered as soon as possible after the initiation of anti-TB treatment (within 8 weeks) without consideration of the CD4+ T cell count [25]. This evidence concerns the gene CD4 and tuberculosis.